ITP Market Outlook 2025+: Competitive Positioning, Clinical Milestones, and Growth Trends
Immune Thrombocytopenia (ITP), once called idiopathic thrombocytopenic purpura, is a chronic autoimmune disorder characterized by a low platelet count due to immune-mediated destruction and impaired platelet production. Often misunderstood as a simple bleeding disorder, ITP is now increasingly managed through targeted immunomodulation, with treatment strategies evolving beyond...
0 Comments 0 Shares 16 Views 0 Reviews
Sponsored